Sign up to save your podcasts
Or
Share Psoriatic Arthritis & Better Measuring Patient Response to Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Psoriatic Arthritis & Better Measuring Patient Response to Therapy
CME credits: 0.25
Valid until: 23-10-2019
Claim your CME credit at https://reachmd.com/programs/cme/psoriatic-arthritis-better-measuring-patient-response-to-therapy/10405/
When you hear PsA outcome measures, you may instantly think of physician-centered ones, such as assessing disease activity for inflammatory joint disease, skin manifestations, and extra-articular features. While these outcome measures are certainly important, they’re starting to be examined in light of new patient-focused measures like satisfaction with symptom control.
Since this particular measure has a direct impact on a patient’s willingness to accept recommended treatment changes and their quality of life, Dr. Matt Birnholz is joined by Dr. Jeffrey Curtis, Harbert Ball Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, to uncover patient dissatisfaction with symptom control.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 23-10-2019
Claim your CME credit at https://reachmd.com/programs/cme/psoriatic-arthritis-better-measuring-patient-response-to-therapy/10405/
When you hear PsA outcome measures, you may instantly think of physician-centered ones, such as assessing disease activity for inflammatory joint disease, skin manifestations, and extra-articular features. While these outcome measures are certainly important, they’re starting to be examined in light of new patient-focused measures like satisfaction with symptom control.
Since this particular measure has a direct impact on a patient’s willingness to accept recommended treatment changes and their quality of life, Dr. Matt Birnholz is joined by Dr. Jeffrey Curtis, Harbert Ball Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, to uncover patient dissatisfaction with symptom control.